Spots Global Cancer Trial Database for dmmr colorectal cancer
Every month we try and update this database with for dmmr colorectal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy | NCT06414304 | Colorectal Canc... Colorectal Canc... MSI-H Colorecta... dMMR Colorectal... Cancer Colon Adenocarc... | 18 Years - | OncoAtlas LLC | ||
| PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer | NCT04301557 | DMMR Colorectal... MSI-H Colorecta... Locally Advance... | PD-1 Antibody Oxaliplatin Capecitabine External beam r... Total mesorecta... | 18 Years - 72 Years | Sun Yat-sen University | |
| Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery | NCT06262581 | DMMR Colorectal... Anti PD-1 Immunotherapy | Tisleizumab(BGB... | 18 Years - | Sun Yat-sen University | |
| Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery | NCT06262581 | DMMR Colorectal... Anti PD-1 Immunotherapy | Tisleizumab(BGB... | 18 Years - | Sun Yat-sen University | |
| Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy | NCT06414304 | Colorectal Canc... Colorectal Canc... MSI-H Colorecta... dMMR Colorectal... Cancer Colon Adenocarc... | 18 Years - | OncoAtlas LLC | ||
| Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery | NCT06262581 | DMMR Colorectal... Anti PD-1 Immunotherapy | Tisleizumab(BGB... | 18 Years - | Sun Yat-sen University | |
| A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies | NCT04244552 | Breast Cancer Colorectal Canc... Ovarian Cancer Non-Small Cell ... Acral Lentigino... Head and Neck S... Hepatocellular ... Esophageal Squa... Urothelial Carc... DMMR Colorectal... MSI-H Colorecta... Melanoma Platinum-Resist... Platinum-Resist... Platinum-Resist... Triple Negative... | ATRC-101 Pembrolizumab Pegylated lipos... | 18 Years - | Atreca, Inc. | |
| Cadonilimab in Locally Advanced MSI-H/dMMR Colorectal Cancer | NCT05815290 | dMMR Colorectal... | Cadonilimab | 18 Years - | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery | NCT06262581 | DMMR Colorectal... Anti PD-1 Immunotherapy | Tisleizumab(BGB... | 18 Years - | Sun Yat-sen University | |
| Cadonilimab in Locally Advanced MSI-H/dMMR Colorectal Cancer | NCT05815290 | dMMR Colorectal... | Cadonilimab | 18 Years - | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers | NCT05239546 | Colon Cancer dMMR Colorectal... | Dostarlimab | 18 Years - | University of Iowa |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
